Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
10.99
Dollar change
-0.04
Percentage change
-0.36
%
Index- P/E- EPS (ttm)-6.11 Insider Own1.61% Shs Outstand23.37M Perf Week-3.09%
Market Cap256.84M Forward P/E- EPS next Y-3.02 Insider Trans0.00% Shs Float22.99M Perf Month1.67%
Income-135.12M PEG- EPS next Q-0.99 Inst Own17.91% Short Float9.15% Perf Quarter18.94%
Sales0.83M P/S309.44 EPS this Y36.75% Inst Trans54.59% Short Ratio4.31 Perf Half Y72.80%
Book/sh5.15 P/B2.13 EPS next Y21.60% ROA-51.59% Short Interest2.10M Perf Year-2.31%
Cash/sh6.22 P/C1.77 EPS next 5Y41.50% ROE-79.55% 52W Range3.89 - 14.75 Perf YTD79.58%
Dividend Est.- P/FCF- EPS past 5Y13.49% ROI-105.25% 52W High-25.48% Beta1.16
Dividend TTM- Quick Ratio3.60 Sales past 5Y60.80% Gross Margin-321.09% 52W Low182.66% ATR (14)0.96
Dividend Ex-Date- Current Ratio3.60 EPS Y/Y TTM57.05% Oper. Margin-16036.65% RSI (14)48.10 Volatility6.73% 8.39%
Employees122 Debt/Eq0.26 Sales Y/Y TTM-91.89% Profit Margin-16239.85% Recom2.20 Target Price19.25
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q56.92% Payout- Rel Volume0.53 Prev Close11.03
Sales Surprise-71.39% EPS Surprise7.25% Sales Q/Q-17.66% EarningsMar 06 AMC Avg Volume487.43K Price10.99
SMA20-6.90% SMA5014.33% SMA20066.52% Trades Volume256,949 Change-0.36%
Date Action Analyst Rating Change Price Target Change
Jan-25-24Upgrade Oppenheimer Perform → Outperform $4
Nov-09-22Downgrade Maxim Group Buy → Hold
Nov-01-22Downgrade BofA Securities Neutral → Underperform $2
Jul-19-22Resumed RBC Capital Mkts Sector Perform $5 → $4
May-11-22Downgrade Oppenheimer Outperform → Perform
Jan-21-22Upgrade BofA Securities Underperform → Neutral $8 → $10
Dec-29-21Resumed Jefferies Hold $8 → $6
Sep-10-21Downgrade BofA Securities Neutral → Underperform $9 → $8
Jun-24-21Initiated Jefferies Hold $9
Mar-23-21Initiated BofA Securities Neutral $13
Apr-15-24 06:39PM
Mar-26-24 06:28PM
Mar-08-24 09:55AM
Mar-07-24 10:38AM
06:39AM
11:30PM Loading…
Mar-06-24 11:30PM
09:54PM
04:05PM
07:00AM
Feb-21-24 09:55AM
08:00AM
Feb-12-24 06:25AM
Feb-07-24 11:46AM
Feb-02-24 08:00AM
Jan-30-24 09:55AM
09:13AM Loading…
Jan-24-24 09:13AM
Jan-23-24 08:00AM
Jan-22-24 08:00AM
Jan-12-24 09:43AM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Nov-14-23 10:56AM
Nov-10-23 03:38PM
12:00AM
Nov-09-23 04:42PM
04:05PM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 09:53AM
Oct-10-23 08:00AM
11:10AM Loading…
Sep-28-23 11:10AM
Sep-27-23 07:39PM
Sep-07-23 08:00AM
Sep-06-23 09:31PM
Aug-29-23 08:00AM
Aug-09-23 08:30PM
05:40PM
04:38PM
04:05PM
Aug-04-23 08:00AM
Jul-26-23 09:32AM
Jun-23-23 04:10PM
Jun-01-23 08:00AM
May-25-23 08:00AM
May-23-23 04:13PM
May-15-23 12:00PM
06:08AM
May-13-23 08:20AM
May-12-23 06:14AM
May-11-23 03:30AM
May-10-23 05:45PM
04:05PM
May-08-23 08:00AM
May-05-23 08:00AM
Apr-28-23 08:00AM
Apr-27-23 08:00AM
Apr-26-23 08:00AM
Apr-17-23 01:55PM
08:00AM
Apr-13-23 02:07PM
Apr-12-23 08:00AM
Apr-04-23 03:10PM
Apr-03-23 08:00AM
Mar-06-23 01:07AM
Mar-03-23 08:00AM
Mar-01-23 07:00PM
06:15PM
04:05PM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-03-23 08:00AM
Feb-02-23 01:39PM
08:00AM
Feb-01-23 01:55PM
Jan-31-23 11:40AM
11:07AM
08:00AM
Jan-03-23 07:27AM
Nov-18-22 11:42AM
11:02AM
Nov-17-22 04:30PM
09:23AM
Nov-08-22 10:00PM
06:25PM
04:57PM
04:05PM
Oct-28-22 04:27PM
12:37PM
08:50AM
Oct-27-22 04:30PM
Oct-26-22 10:41AM
Oct-25-22 08:00AM
Oct-21-22 06:02PM
Oct-17-22 05:59PM
Oct-13-22 10:30AM
08:00AM
Sep-25-22 09:05AM
Sep-11-22 10:53AM
Sep-07-22 10:12AM
Sep-01-22 08:00AM
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zoth Lota S.DirectorJun 05 '23Sale0.565,7003,19252,716Jun 05 04:13 PM